Navigation Links
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Date:4/8/2013

DCVax-L for brain cancer, in both the US and Europe;
  • initiation of the DCVax-Direct program;
  • commencement of a "Specials" program (similar to compassionate use) for brain cancer patients not eligible for the Phase III trial in the UK to obtain DCVax-L on a self-pay basis;
  • completion of a 6-month Scientific Advice process with regulators, with positive feedback, and application for a "Hospital Exemption" program (similar to compassionate use) in Germany for brain cancer patients not eligible for the Phase III trial to obtain DCVax-L on a self-pay basis;
  • assistance to 10 major hospital centers in Germany (including all key opinion leaders in brain cancer) preparing and submitting applications to the German healthcare system requesting authorization of reimbursement for DCVax-L;
  • doubling of manufacturing capacity for DCVax-L in US;
  • completion of extensive regulatory processes and inspections, and receipt of approval, for manufacturing of DCVax-L in Germany for Phase III clinical trial; 
  • additional regulatory processes in both UK and Germany for supply of DCVax-L products from Germany to UK for Phase III trial in UK;
  • technology transfer and regulatory processes for manufacturing of DCVax-L in UK;
  • partnering arrangements with several large marquee partners in the US and Europe;
  • initiation of manufacturing preparations in US for DCVax-Direct Phase I/II trial;
  • award of a $5.5 million non-dilutive matching grant from the German government (one of the largest such grants ever awarded), which the Company plans to start drawing  in Q2 of 2013;
  • comprehensive clean-up of the Company's balance sheet (eliminating more than $36 million in debt);
  • financings totaling over $32 million;
  • listing of the Company's Common Stock and Warrants on the Nasdaq Capital Markets;
  • expansion of the Company's management team with a veteran sen
    '/>"/>

  • SOURCE Northwest Biotherapeutics
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related biology technology :

    1. DIA 2013 49th Annual Meeting to Address Hot Topics Surrounding Patient Therapies
    2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
    3. Susan Cain Will Kick Off 2013 ASAE Annual Meeting & Exposition, Dan Heath is Closing General Session Speaker
    4. Electronic Headband That Detects and Treats Addictive In-Sleep Behavior to be Demonstrated at Annual Holistic Dental Conference by Holistic Technologies
    5. Professional Pricing Society Explores New Role of Pricers as Change Agents and Leaders at 24th Annual Spring Conference
    6. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
    7. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
    8. Smith & Nephew hosts thought-leading surgeons, showcases new technology at American Academy of Orthopaedic Surgeons annual meeting
    9. Archimedes Inc. Renews Annual Marketing Agreement with HealthEconomics.Com
    10. Palatin Technologies To Present At The 25th Annual ROTH Conference
    11. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... , Nueva Jersey , 22 de enero ... for Biomedical Research abre hoy su llamada a nominaciones ... cuya investigación científica ha hecho, o tiene el potencial ... salud humana. Las nominaciones se aceptarán hasta el 15 ...
    (Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
    (Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq:   ... disease, announced today that the Company closed its ... Investment Management, Jack W. Schuler , Birchview ... were $10.5 million, before offering expenses.  The proceeds ...
    (Date:12/24/2014)... 2014 Earlier this year in a June ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... property of adult tissue stem cells. His title “Asymmetric ... for the Future,” embodied the essence of his message to ...
    Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
    ... question regarding man,s existence has been left unanswered by ... homosexuals don,t naturally reproduce, their gene pool is not ... survival and existence?  What if their existence served a ... we,re to believe Darwin,s laws of evolution, the mere ...
    ... Mass., June 14, 2011 Sensitech,s TempTale®4 (TT4) ... advanced and flexible range of configurable alarm options ... global supply chain by allowing for more precise, ... design gives users the ability to program up ...
    ... Merriman Capital, Inc., a wholly ... MERR ), today announced that it will serve as ... (ASX: CIR; OTCQX: CKDXY) as it begins trading on ... Circadian is an Australian biotechnology company developing innovative, ...
    Cached Biology Technology:Sensitech® Inc.'s TempTale®4 Multi-Alarm Temperature Monitors Offer Highly Advanced and Flexible Range of Configurable Alarm Options 2Sensitech® Inc.'s TempTale®4 Multi-Alarm Temperature Monitors Offer Highly Advanced and Flexible Range of Configurable Alarm Options 3Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX 2Merriman Capital Announces Sponsorship of Circadian Technologies on OTCQX 3
    (Date:12/22/2014)... 2014 Holiday Season may be the brightest ever for ... the long anticipated floodgates for consumer biometrics may finally ... phones, tablets, and wearable mobile devices that incorporate biometrics ... with nearly 4.8 billion biometric devices by 2020.   ...
    (Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
    (Date:12/17/2014)... , Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ...
    Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
    ... immune system defects, visual pathologies, heart disease. A ... providing an excellent model system to unravel these ... worldwide are currently working with this organism and ... health; Spain is among the leading countries for ...
    ... more open to the idea of "designing" babies than the ... the University of East Anglia. , The findings will be ... Science on Setpember 5. , Dr. Hampton and his team ... what different groups of people in the UK would "design ...
    ... discovered on an unexplored mountain range in northern ... Conservation Programme. It was named "Yariguies Brush-Finch," with ... The new brush-finch was described by an Anglo-Colombian ... and Blanca Huertas (Natural History Museum and University ...
    Cached Biology News:A valuable fly for research into disease 2Designer babies - what would you do for a 'healthy' baby? 2New bird discovered on unexplored Columbian mountain 2
    ... ultimate in utility and flexibility press-to-seal silicone ... needs of the researcher. They are available ... as sheet material that can be easily ... are autoclavable and non-cytotoxic and can be ...
    Argon Calibration Source...
    SHEEP ANTI ESCHERICHIA COLI...
    Recombinant Rat Leptin, CF...
    Biology Products: